Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept
2013-003413-18Phase 2Unknown
- Sponsor
- King's College London
- Start
- Apr 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of abatacept in rheumatoid arthritis (RA) and arthralgia, sponsored by King's College London. Primary endpoint: Time to development of clinically apparent synovitis in ≥ 3 joints. Status: unknown.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)arthralgia
Beyond the preview
Go deeper on 2013-003413-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003413-18.